aTyr Pharma, Inc. Common Stock
€0.33585
EUR
Last updated on --.
24h volume109.01M
24h highest0.61984 EUR
24h lowest0.31827 EUR
24h Price movement+1.81%
ATYR recent prices
24 Hours
+1.81%+€0.0059786
30 days
-34.23%-€0.17153
60 days
-23.43%-€0.10084
90 days
-28.93%-€0.13417
Key data
Previous close0.32988 EUR
Market cap31.30M EUR
Volume109.01M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.54510 EUR
Net income (FY)-53.47M EUR
Revenue (FY)167.05K EUR
Last report dateAug 7, 2026
About aTyr Pharma, Inc. Common Stock
HeadquartersSAN DIEGO
Employees (FY)58.00
Revenue per employee (FY)2.88K EUR
Net income per employee (FY)-921.83K EUR
Listed onNasdaq
ATYR conversion tables
 |  |
|---|---|
| 0.5 ATYR | 0.16793 EUR |
| 1 ATYR | 0.33585 EUR |
| 5 ATYR | 1.679 EUR |
| 10 ATYR | 3.358 EUR |
| |
|---|---|
| 0.5 EUR | 1.488 ATYR |
| 1 EUR | 2.977 ATYR |
| 5 EUR | 14.88 ATYR |
| 10 EUR | 29.77 ATYR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ATYR is trading at €0.33585, +1.81% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ATYR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ATYR is currently trading at €0.33585, +1.81% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ATYR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ATYR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ATYR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ATYR's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
aTyr Pharma, Inc. Common Stock's market cap is currently 31.30M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume109.01M
24h highest0.61984 EUR
24h lowest0.31827 EUR
24h Price movement+1.81%
Start trade with ATYR Perpetual
Sign up to trade